Lexicon Pharmaceuticals, Inc. (LXRX) Social Stream



Lexicon Pharmaceuticals, Inc. (LXRX): $2.40

0.21 (+9.59%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add LXRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#342 of 365

in industry

Featured Post From StockTwits About LXRX

$LXRX Looking like Covid is having a knock on with diabetes...

Now reports of newly diagnosed DM in Covid patients and also reports of previously well controlled DM that after infection and some after vaccination, now have lost control and cannot get their glucose down to a reasonable level despite changing medication.

There is also the unknown amount of future people with Myocarditis and Pericarditis from the Vaccines, as well as the damage to the heart from Covid it`s self.

One could consider a larger market and health requirement for medications to treat.

Depending on Jardiance and results on the 27th August, LXRX could have a good future... just need to get it through the FDA..
Siggy74, published August 13, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!